Update: Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years

By SharpBrains | December 30, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, shar­ing impor­tant brain/ men­tal health news plus a few fun opti­cal illu­sions to tease and appre­ci­ate our unique human minds. #1. Why MDMA-assist­ed psy­chother­a­py may become an FDA-approved treat­ment for PTSD with­in 2 years “We are a phar­ma­cist and physi­cian team who inves­ti­gate the ben­e­fits and harms asso­ci­at­ed with…

Read More

Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years

By The Conversation | December 21, 2021

For peo­ple with post-trau­­mat­ic stress dis­or­der, recall­ing mem­o­ries of phys­i­cal or sex­u­al assault, com­bat or dis­­as­ter-relat­ed events can induce intense anx­i­ety or pan­ic attacks as well as debil­i­tat­ing flash­backs. In the U.S., about 7% of peo­ple suf­fer from PTSD and lose an aver­age of about four work­ing days each month as a result. Trau­­ma-spe­­cif­ic psychotherapy,…

Read More